Organogenesis Holdings (ORGO) Cost of Revenue (2017 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Cost of Revenue of $25.8 million for Q1 2026, up 8.64% year-over-year from $23.7 million in Q1 2025, and down 48.37% quarter-over-quarter from $49.9 million in Q4 2025.
Organogenesis Holdings (ORGO) Cost of Revenue (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Cost of Revenue history runs 10 years deep, the most recent figure standing at $25.8 million for Q1 2026.
- In Q1 2026, Cost of Revenue rose 8.64% year-over-year to $25.8 million; the TTM figure through Mar 2026 stood at $139.6 million (up 26.0% YoY), while the FY2025 annual figure was $137.5 million, up 18.82% from the prior year.
- Cost of Revenue for Q1 2026 stood at $25.8 million, down from $49.9 million in the prior quarter.
- The five-year high for Cost of Revenue was $49.9 million in Q4 2025, with the low at $23.7 million in Q1 2025.
- The 5-year median for Cost of Revenue is $26.8 million (2024), against an average of $28.9 million.
- Peak annual rise in Cost of Revenue reached 60.76% in 2025, while the deepest fall reached 17.33% in 2025.
- Organogenesis Holdings' Cost of Revenue stood at $27.1 million in 2022, then increased by 2.43% to $27.8 million in 2023, then advanced by 11.82% to $31.1 million in 2024, then surged by 60.76% to $49.9 million in 2025, then tumbled by 48.37% to $25.8 million in 2026.
- Business Quant data shows ORGO's Cost of Revenue at $25.8 million in Q1 2026, $49.9 million in Q4 2025, and $36.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Organogenesis Holdings | 242.55 Mn | 195.71 Mn | 20.08 Mn | 23.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.67 Mn |
| Jun 30, 2026 | 23.67 Mn |
| Mar 31, 2026 | 25.77 Mn |
| Mar 31, 2026 | 25.77 Mn |
| Dec 31, 2025 | 49.92 Mn |
| Dec 31, 2025 | 49.92 Mn |
| Sep 30, 2025 | 36.25 Mn |
| Sep 30, 2025 | 36.25 Mn |
| Jun 30, 2025 | 27.63 Mn |
| Jun 30, 2025 | 27.63 Mn |
| Mar 31, 2025 | 23.72 Mn |
| Mar 31, 2025 | 23.72 Mn |
| Dec 31, 2024 | 31.05 Mn |
| Dec 31, 2024 | 31.05 Mn |
| Sep 30, 2024 | 26.80 Mn |
| Sep 30, 2024 | 26.80 Mn |
| Jun 30, 2024 | 29.20 Mn |
| Jun 30, 2024 | 29.20 Mn |
| Mar 31, 2024 | 28.70 Mn |
| Mar 31, 2024 | 28.70 Mn |